Featured news / 29 January 2010 /
Synbiosis, a world-leading manufacturer of automated microbiological systems, is delighted to introduce ProcUV, its new UV imaging accessory for the ProtoCOL 2 system. ProcUV permits instant imaging of fluorescent colonies and plaques so they can be automatically counted or analysed by ProtoCOL 2, thus saving time and improving accuracy of results.
Featured news / 8 December 2009 /
Synbiosis, a world-leading manufacturer of automated microbiological systems, announced its ProtoCOL 2 system for colony counting and inhibition zone analysis has been upgraded to allow rapid statistical analysis of flu and bacterial vaccine potency and antibiotic susceptibility testing results.
Featured news / 27 November 2009 /
Synbiosis, a world-leading manufacturer of automated microbiological systems, is pleased to announce that its innovative ProtoCOL 2 automatic zone measuring system can increase the speed of quality testing of H1N1 swine flu virus vaccine potency, ensuring vaccines can be rapidly delivered to healthcare professionals.
Featured news / 27 November 2009 /
Synbiosis, a world-leading manufacturer of automated microbiological systems, is pleased to announce its new ProtoCOL 2 automated zone measuring system now offers unique functionality for analysing antibiotic susceptibility testing plates. This can help improve quality testing and speed up the release of new antibiotics, thus reducing the spread of drug resistance.
Featured news / 13 October 2009 /
Synbiosis, a world-leading manufacturer of automated microbiological systems, is pleased to announce the availability of its ProtoCOL 2 series brochure, which details how its automated colony counting and zone measurement range can increase accuracy and productivity in many microbiology applications.
Featured news / 29 September 2009 /
Cambridge, UK: Synbiosis, a world-leading manufacturer of automated microbiological systems, is delighted to announce that one of the world’s largest WHO pre-qualified vaccine suppliers, Bio Farma in Indonesia is using a ProtoCOL system to speed up the quality testing of its seasonal flu vaccines.
Featured news / 29 September 2009 /
Cambridge, UK: Synbiosis, a world-leading manufacturer of automated microbiological systems, has launched its new ProtoCOL 2 system for rapid, accurate automated colony counting and zone measurement.
Featured news / 29 September 2009 /
Cambridge, UK: Synbiosis, a world-leading manufacturer of automated microbiological systems, is pleased to announce its ProtoCOL automatic zone measuring system has new features, designed to improve the speed of analysing SRD plates, ensuring flu vaccines can be manufactured more rapidly.
Featured news / 29 September 2009 /
Cambridge, UK: Synbiosis, a world-leading manufacturer of automated microbiological systems, is pleased to announce its ProtoCOL automated colony counter offers new features to guarantee the fastest, most accurate testing of pneumococcal vaccines using an OPKA assay.
Featured news / 29 September 2009 /
Cambridge, UK: Synbiosis, a world-leading manufacturer of automated microbiological systems, is delighted to announce that ACE BioSciences, a Danish biotech developing innovative vaccines, is using a ProtoCOL automated colony counter to significantly speed up potency testing of its novel pneumococcal vaccines.
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
© Russell Publishing Limited, 2010-2012. All rights reserved | Website design and development by e-Motive Media | Terms & conditions of use | Privacy policy
Login to access exclusive content